Apollon Wealth Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
1,035
-286
| -22% | -$62.6K | ﹤0.01% | 1126 |
|
|
2025
Q1 | $296K | Buy |
1,321
+126
| +11% | +$28.2K | 0.01% | 959 |
|
|
2024
Q4 | $391K | Sell |
1,195
-67
| -5% | -$21.9K | 0.01% | 845 |
|
|
2024
Q3 | $379K | Buy |
1,262
+1
| +0.1% | +$300 | 0.01% | 826 |
|
|
2024
Q2 | $415K | Sell |
1,261
-126
| -9% | -$41.5K | 0.01% | 751 |
|
|
2024
Q1 | $549K | Sell |
1,387
-163
| -11% | -$64.5K | 0.02% | 662 |
|
|
2023
Q4 | $546K | Sell |
1,550
-74
| -5% | -$26.1K | 0.02% | 625 |
|
|
2023
Q3 | $609K | Buy |
1,624
+296
| +22% | +$111K | 0.03% | 496 |
|
|
2023
Q2 | $508K | Sell |
1,328
-1,678
| -56% | -$642K | 0.02% | 585 |
|
|
2023
Q1 | $1.04M | Sell |
3,006
-323
| -10% | -$112K | 0.06% | 315 |
|
|
2022
Q4 | $784K | Buy |
3,329
+1,001
| +43% | +$236K | 0.06% | 370 |
|
|
2022
Q3 | $573K | Buy |
2,328
+257
| +12% | +$63.3K | 0.05% | 409 |
|
|
2022
Q2 | $626K | Buy |
2,071
+448
| +28% | +$135K | 0.05% | 375 |
|
|
2022
Q1 | $667K | Buy |
1,623
+175
| +12% | +$71.9K | 0.05% | 382 |
|
|
2021
Q4 | $679K | Buy |
1,448
+50
| +4% | +$23.4K | 0.05% | 393 |
|
|
2021
Q3 | $594K | Sell |
1,398
-361
| -21% | -$153K | 0.08% | 236 |
|
|
2021
Q2 | $632K | Buy |
+1,759
| New | +$632K | 0.11% | 189 |
|